Skip To Main Content
Michael Portman on Muck Rack

Michael Portman

Kansas City
As seen in: JAMA (The Journal of the American Medical Association), Pediatrics, WPTV-TV (West Palm Beach, FL), Healio Cardiology, WANF-TV (Atlanta, GA), KPTV-TV (Beaverton, OR), KVVU-TV (Henderson, NV), KMOV-TV (St. Louis, MO), WHNS-TV (Greenville, SC), WAFB-TV (Baton Rouge, LA) and
KU alum. A Texan in KC. HOA GC Asst. Manager, Golf Marketer and improving my Golf game.🏌️‍♂️Former news junkie (jk still am) and former PR specialist.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Michael

Contact Michael, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Edoxaban for Thromboembolism Prevention in Pediatric Patients With Cardiac Disease:

|
By Michael Portman, Jeffrey P. Jacobs, Jane W. Newburger, Felix Berger
| JACC (Journal of the American College of Cardiology)
JACC Journals › JACC › Archives › Vol. 80 No. 24 Abstract Background Standard of care (SOC) anticoagulation for thromboembolism (TE) prevention in children with cardiac disease includes low molecular weight heparins or vitamin K antagonists. Limited data exists for alternate use of direct oral anticoagulants in children. Objectives The investigators aimed to obtain safety and efficacy data for edoxaban in children.
Open in Who Shared Issue with article?

Edoxaban better alternative vs. standard care for children at risk for blood clots

|
By Regina Schaffer Verified, Erik Swain Verified, Michael Portman
| Healio Cardiology Verified
Source/Disclosures Source: Portman MA, et al. Abstract 316. Presented at: American Heart Association Scientific Sessions; Nov. 5-7, 2022; Chicago (hybrid meeting). Disclosures: Portman reports financial ties with Daichi Sankyo and Kiniksa. Source/Disclosures Source: Portman MA, et al. Abstract 316. Presented at: American Heart Association Scientific Sessions; Nov. 5-7, 2022; Chicago (hybrid meeting). Disclosures: Portman reports financial ties with Daichi Sankyo and Kiniksa.
Open in Who Shared Issue with article?

Management of MIS-C (Multi-system Inflammatory Syndrome in Children): Decision-making regarding a new condition in the absence of clinical trial data

|
By Ashraf S. Harahsheh, Michael Portman, Michael Khoury, Matthew D. Elias
| Canadian Journal of Cardiology Verified
Article Info Publication History Accepted: November 24, 2022 Received in revised form: November 22, 2022 Received: October 21, 2022 Publication stage In Press Journal Pre-Proof Footnotes Acknowledgments: The authors are grateful for Angela J. Doty, MD for her editorial assistance and for everyone treating and researching MIS-C along with our patients and their families.
Open in Who Shared Issue with article?
See all 905 articles